Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood Cells, Molecules & Diseases

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BCMD.2004.03.001PMID 15223015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aminopropyl solid phase extraction and 2 D TLC of neutral glycosphingolipids and neutral lysoglycosphingolipids Published, JLR Papers in Press, October 1, 2002. DOI 10.1194/jlr.D200026-JLR200

  2003cited by this paper
• Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide

  2002cited by this paper
• Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?

  2001cited by this paper
• Chemotherapy by slowing glucosphingolipid synthesis.

  1999cited by this paper
• Glucosylceramides stimulate mitogenesis in aged murine epidermis.

  1998cited by this paper
• Membranous Lamellar Cytoplasmic Inclusions in Histiocytes and Mesothelial Cells of Serous Fluids

  1998cited by this paper
• Role of lipid metabolites in the signalling and activation of macrophage cells by lipopolysaccharide.

  1997cited by this paper
• Analysis of the lipids of normal and Gaucher bone marrow.

  1996cited by this paper
• Glucosylceramides stimulate murine epidermal hyperproliferation.

  1995cited by this paper
• A Regulatory Role for Sphingolipids in Neuronal Growth

  1995cited by this paper
• Coordination of membrane phospholipid synthesis with the cell cycle.

  1994cited by this paper
• Sphingosine inhibits the activity of rat liver CTP:phosphocholine cytidylyltransferase.

  1990cited by this paper
• The metabolism of glycerophospholipid and its regulation in monocytes and macrophages.

  1989cited by this paper
• Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.

  1988cited by this paper
• Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.

  1988cited by this paper
• Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.

  1988cited by this paper
• Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures.

  1981cited by this paper
• Characterization of the cytoplasmic inclusion bodies of the spleens from patients with adult form Gaucher's disease.

  1980cited by this paper
• Fetal pathology and ultrastructure of neuropathic Gaucher's disease.

  1976cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Choline metabolism underpins macrophage IL-4 polarization and RELMα up-regulation in helminth infection

  2023cites this paper
• Murine macrophage choline metabolism underpins IL-4 polarization and RELM up-regulation

  2022cites this paper
• Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease

  2021cites this paper
• First mitochondrial genome-wide association study with metabolomics

  2021cites this paper
• Choline Regulates the Function of Bovine Immune Cells and Alters the mRNA Abundance of Enzymes and Receptors Involved in Its Metabolism in vitro

  2018cites this paper
• Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.

  2016cites this paper
• From sheep to mice to cells: tools for the study of the sphingolipidoses.

  2014cites this paper
• Gaucher disease: a diagnostic challenge for internists.

  2014cites this paper
• BETA-GLUCOSIDASE 2 ( GBA 2 ) ACTIVITY AND IMINO SUGAR PHARMACOLOGY

  2013cites this paper
• β-Glucosidase 2 (GBA2) Activity and Imino Sugar Pharmacology*

  2013cites this paper
• Investigation of the linkage between Gaucher disease and BCelldisorders including multiple myeloma

  2011cites this paper
• Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.

  2011cites this paper
• Impact of glycosphingolipid accumulation on the immunological system

  2011cites this paper
• Homocysteine as a Risk Factor for Atherosclerosis: Is Its Conversion to S-Adenosyl-L-Homocysteine the Key to Deregulated Lipid Metabolism?

  2011cites this paper
• Métabolisme lipidique et cycle du glyoxylate chez la levure Yarrowia lipolytica. (Lipid metabolism and glyoxylate cycle in the yeast Yarrowia lipolytica)

  2010cites this paper
• Impaired IL-10 transcription and release in animal models of Gaucher disease macrophages.

  2009cites this paper
• Lipidomics in diagnosis of lipidoses.

  2008cites this paper
• Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants.

  2008cites this paper
• Covalent inhibitors of glycosidases and their applications in biochemistry and biology.

  2008cites this paper
• Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention.

  2008cites this paper
• Phosphatidylcholine is essential for efficient functioning of the mitochondrial glycerol-3-phosphate dehydrogenase Gut2 in Saccharomyces cerevisiae

  2007cites this paper
• Increased lung surfactant phosphatidylcholine in patients affected by lysosomal storage diseases

  2007cites this paper
• Identification of the Non-lysosomal Glucosylceramidase as β-Glucosidase 2*

  2007cites this paper
• Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha.

  2007cites this paper
• Secondary sphingolipid accumulation in a macrophage model of Gaucher disease.

  2007cites this paper
• Neuronal Cell Death in Glycosphingolipidoses

  2006cites this paper
• Genetic diseases of sphingolipid metabolism: Pathological mechanisms and therapeutic options

  2006cites this paper
• Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC‐class II: monocytes from Gaucher disease patients as a model

  2005cites this paper
• Gaucher disease: pathological mechanisms and modern management

  2005cites this paper
• The pathogenesis of glycosphingolipid storage disorders.

  2004cites this paper
• Elevation of lung surfactant phosphatidylcholine in mouse models of Sandhoff and of Niemann–Pick A disease

  2004cites this paper